A Public Citizen press release announces a report on a sprawling unregulated market for retatrutide, an Eli Lilly weight loss drug not FDA-approved for use outside clinical trials. The report says at least 14 hospitalizations are linked to the drug, that companies and influencer affiliates like Braden Peters openly promote self-injection, and that many firms warned by the FDA still sell it despite little sign of tougher sanctions.